A Biomarker to Detect Salt Sensitivity
Use of NT-proBNP as a Biomarker to Treat Salt Sensitive in Hypertensive Individuals
1 other identifier
observational
30
1 country
1
Brief Summary
The investigators are proposing that individuals with elevated levels of NT-proBNP are resistant to natriuretic peptides and are unable to handle sodium loads and maintain optimal blood pressure values.The investigators will test this hypothesis by comparing the blood pressure response to low and high salt diets in individuals with pre- or hypertension and who have normal or elevated levels of NT-proBNP. The investigators expect that blood pressure values in those with normal levels of NT-proBNP will not change with high salt diets, whereas, in those with elevated levels of NT-proBNP, blood pressure values will increase significantly when exposed to high salt diets.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 8, 2017
CompletedFirst Posted
Study publicly available on registry
May 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedApril 18, 2019
April 1, 2019
2.5 years
May 8, 2017
April 17, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in blood pressure
Difference in blood pressure before and after diets periods and comparison between those with normal and elevated blood levels of NT-proBNP.
9 weeks
Secondary Outcomes (1)
Ratio of BNP/cGMP
9 weeks
Interventions
Effects of high and low salt diets on blood pressure in individuals with normal and elevated levels of NT-proBNP
Eligibility Criteria
Pre- or hypertensive individuals without chronic complications, between the ages of 30 and 75 years, not on blood pressure lowering medications.
You may qualify if:
- Systolic blood pressure \> 120 and \< 160 mmHg
- Diastolic blood pressure \> 80 and \< 100 mmHg
- Not on hypertensive medications
- NT-proBNP between 40 - 99 pg/mL (healthy levels)
- NT-proBNP \> 120 pg/mL (elevated levels)
You may not qualify if:
- Physician reported diabetes or on insulin or oral hypoglycemic agents
- BMI \> 40kg/m2
- Age \< 30 or \> 75 years
- Presence of cardiovascular disease or chronic kidney disease
- Chronic obstructive pulmonary disease or pulmonary arterial hypertension
- Aldosterone secreting disorder
- Estimated energy intake greater than 3400 calories
- Pregnancy
- Individuals with pacemakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota Medical Center
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Otto A Sanchez, MD PhD
University of Minnesota
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2017
First Posted
May 10, 2017
Study Start
January 1, 2016
Primary Completion
June 30, 2018
Study Completion
December 31, 2018
Last Updated
April 18, 2019
Record last verified: 2019-04